Nutritional significance of milk lipids

Advanced Dairy Chemistry

Volumn 2, Issue , 2009, Pages 601-639

  Parodi, P W ^a  

^a Human Nutrition and Health Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885804655     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-28813-9_17     Document Type: Chapter

References (120)

1. Ahrens, E.H., Hirsch, J., Insull, W., Tsaltas, T.T., Blomstrand, R., Peterson, M.L. 1957. The influence of dietary fats on serum-lipid levels in man. Lancet. 1, 943-953.
2. Anderson, K.M., Castelli, W.P., Levy, D. 1987. Cholesterol and mortality. 30 Years of followup from the Framingham Study. J. Am. Med. Assoc. 257, 2176-2180.
3. Aro, A., Mannisto, S., Salminen, I., Ovaskainen, M-l., Kataja, V., Uusitupa, M. 2000. Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr. Cancer. 38, 151-157.
4. Ascherio, A., Hennekens, C.H., Buring, J.E., Master, C., Stampfer, M.J., Willet, W.C. 1994. Trans-fatty acids intake and risk of myocardial infarction. Circulation. 89, 94-101.
5. Ascherio, A., Katan, M.B., Zock, P.L., Stampfer, M.J., Willett, W.C. 1999. Trans fatty acids and coronary heart disease. N. Engl. J. Med. 340, 1994-1998.
6. Banni, S., Angioni, E., Murru, E., Carta, G., Melis, M.P., Bauman, D., Dong, Y., Ip, C. 2001. Vaccenic acid feeding increases tissue levels of conjugated linoleic acid and suppresses development of premalignant lesions in rat mammary gland. Nutr. Cancer. 41, 91-97.
7. Belobrajdic, D.P., McIntosh, G.H. 2000. Dietary butyrate inhibits NMU-induced mammary cancer in rats. Nutr. Cancer. 36, 217-223.
8. Belury, M. 2002. Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J. Nutr. 132, 2995-2998.
9. Bolton-Smith, C., Woodward, M., Fenton, S., Brown, C.A. 1996. Does dietary trans fatty acid intake relate to the prevalence of coronary heart disease in Scotland? Eur. Heart J. 17, 837-845.
10. Braunwald, E. 1997. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337, 1360-1369.
11. Brown, J.M., Boysen, M.S., Jensen, S.S., Morrison, R.F., Storkson, J., Lea-Currie, R., Pariza, M., Mandrup, S., McIntosh, M.K. 2003. Isomer-specific regulation of metabolism and PPARg signalling by CLA in human preadipocytes. J. Lipid Res. 44, 1287-1300.
12. Bucher, H.C., GriYth, L.E., Guyatt, G.H. 1999. Systematic review of the risk and benefit of different cholesterol-lowering interventions. Arterioscler. Thromb. Vasc. Biol. 19, 187-195.
13. Conley, B.A., Erorin, M.J., Tait, N., Rosen, D.M., Sausville, E.A., Dover, G., Fram, R.J., Van Echo, D.A. 1998. Phase 1 study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin. Cancer Res. 4, 629-634.
14. Connor, W.E. 1961. Dietary cholesterol and the pathogenesis of atherosclerosis. Geriatrics. 407-415.
15. Cooper, D.A. 2004. Carotenoids in health and disease; recent scientific evaluations, research recommendations and the consumer. J. Nutr. 134, 221S-224S.
16. Davey Smith, G., Song, F., Sheldon, T.A. 1993. Cholesterol lowering and mortality: the importance of considering initial level of risk. Br. Med. J. 306, 1367-1373.
17. Davie, J.R. 2003. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133, 2485S-2493S.
18. de Lorgeril, M., Renaud, S., Mamelle, N., Salen, P., Martin, J-L., Monjaud, I., Guidollet, J., Touboul, P., Delaye, J. 1994. Mediterranean alpha-linoleic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 343, 1454-1459.
19. Desvergne, B., Wahli, W. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20, 649-688.
20. Dillehay, D.L., Webb, S.K., Schmelz, E-M., Merrill, A.H. 1994. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J. Nutr. 124, 615-620.
21. Duan, R-D. 1998. Sphingomyelin hydrolysis in the gut and clinical implications in colorectal tumorigenesis and other gastrointestinal diseases. Scand. J. Gastroenterol. 33, 673-678.
22. Egorin, M.J., Yuan, Z-M., Sentz, D.L., Plaisance, K., Eiseman, J.L. 1999. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemother. Pharmacol. 43, 445-453.
23. Elwood, P.C., Pickering, J.E., Hughes, J., Fehily, A.M., Ness, A.R. 2004. Milk drinking, ischaemic heart disease and ischaemic stroke. 2. Evidence from cohort studies. Eur. J. Clin. Nutr. 58, 718-724.
24. El-Sohemy, A., Kendall, C.W.C., Rao, A.V., Archer, M.C., Bruce, W.R. 1996a. Dietary cholesterol inhibits the development of aberrant crypt foci in the colon. Nutr. Cancer. 25, 111-117.
25. El-Sohemy, A., Bruce, W.R., Archer, M.C. 1996b. Inhibition of rat mammary tumorigenesis by dietary cholesterol. Carcinogenesis. 17, 159-162.
26. Friedman, J.M. 2003. A war on obesity, not the obese. Science. 299, 856-858.
27. Gillman, M.W., Cupples, L.A., Gagnon, D., Millen, B.E., Ellison, R.C., Castelli, W.P. 1997. Margarine intake and subsequent coronary heart disease in men. Epidemiology. 8, 144-149.
28. Giovannucci, E., Goldin, B. 1997. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am. J. Clin. Nutr. 66, 1564S-1571S.
29. Gurr, M.I. 1994. Nutritional significance of lipids. In: Advanced Dairy Chemistry: Lipids, Vol. 2, 2nd edn (P.F. Fox, ed.), pp. 349-402, Chapman and Hall, London.
30. Gurr, M.I., Harwood, L.L., Frayn, K.N. 2002. Lipid Biochemistry. 5th edn, Blackwell Science, Oxford.
31. Hansen, C.M., Binderup, L., Hamberg, K.J., Carlberg, C. 2001. Vitamin D and cancer: effects of 1, 25(OH)2D3 and its analogs on growth control and tumorigenesis. Front. Biosci. 6, 820-848.
32. Hertervig, E., Nilsson, A., Bjork, J., Hultkrantz, R., Duan, R-D. 1999. Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation? Br. J. Cancer. 81, 232-236.
33. Hertervig, E., Nilsson, A., Nyberg, L., Duan, R-D. 1997. Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer. 79, 448-453.
34. Holick, M.F. 2004. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 79, 362-371.
35. Holmes, M.D., Hunter, D.J., Colditz, G A., Stampfer, M.J., Hankinson, S.E., Speizer, F.E., Rosner, B., Willett, W.E. 1999a. Association of dietary intake of fat and fatty acids with risk of breast cancer. J. Am. Med. Assoc. 281, 914-920.
36. Holmes, M.D., Stampfer, M.J., Colditz, G.A., Rosner, B., Hunter, D.J., Willett, W.C. 1999b. Dietary factors and the survival of women with breast carcinoma. Cancer. 86, 826-835.
37. Howe, G.R., Aronson, K.J., Benito, E., Castelleto, R., Cornee, J., Duffy, S., Gallagher, R.P., Iscovich, J.M., Deng-ao, J., Kaaks, R., Kune, G.A., Lee, H.P., Lee, M., Miller, A.B., Peters, R.K., Potter, J.D., Riboli, E., Slattery, M.L., Trichopoulos, D., Tuyns, A., Tzonou, A., Watson, L.F., Whittemore, A.S., Wu-Williams, A.H., Shu, Z. 1997. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control. 8, 215-228.
38. Hu, F.B., Stampfer, M.J., Manson, J.E., Ascherio, A., Colditz, G.A., Speizer F.E., Hennekens, C.H., Willett, W.C. 1999. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am. J. Clin. Nutr. 70, 1001-1008.
39. Hu, F.B., Stampfer, M.J., Manson, J.E., Rimm, E., Colditz, G.A., Rosner, B.A., Hennekens, C.H., Willett, W.C. 1997. Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 337, 1491-1499.
40. Hu, F.B., Willett, W.E. 2000. Protein, fat, and ischemic heart disease. Am. J. Clin. Nutr. 71, 848-849.
41. Hubbard, N.E., Lim, D., Erickson, K.L. 2003. Effect of separate conjugated linoleic acid isomers on murine mammary tumorigenesis. Cancer Lett. 190, 13-19.
42. Hunter, D.J., Spiegelman, D., Adami, H-O., Beeson, L., van den Brandt, P.A., Folson, A.R., Fraser, G.E., Goldbohm, R.A., Graham, S., Howe, G.R., Kushi, L.H., Marshall, J.R., McDermott, A., Miller, A.B., Speizer, F.E., Wolk, A., Yaun, S-S., Willett, W.C. 1996. Cohort studies of fat intake and the risk of breast cancer-a pooled analysis. N. Engl. J. Med. 334, 356-361.
43. Ip, C. 1990. Quantitative assessment of fat and calories as risk factors in mammary carcinogenesis in an experimental model. In: Recent Progress in Research on Nutrition and Cancer (C.J. Mettlan, T. Aoki, eds.), pp. 107-117, Wiley-Liss, New York.
44. Ip, C. 1997. Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. Am. J. Clin. Nutr. 66, 1523S-1529S.
45. Ip, C., Chin, S.F., Scimeca, J.A., Pariza, M.W. 1991. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res. 51, 6118-6124.
46. Ip, C., Banni, S., Angioni, E., Carta, G., McGinley, J., Thompson, H.J., Barbano, D., Bauman, D.E. 1999. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J. Nutr. 129, 2135-2142.
47. Ip, M.M., Masso-Welch, P.A., Ip, C. 2003. Prevention of mammary cancer with conjugated linoleic acid: role of stroma and the epithelium. J. Mammary Gland Biol. Neoplasia. 8, 103-118.
48. Kersten, S., Desvergne, B., Wahli, W. 2000. Roles of PPARs in health and disease. Nature. 405, 421-424.
49. Kolonel, L.N. 2001. Fat, meat, and prostate cancer. Epidemiol. Rev. 23, 72-81.
50. Krauss, R.M. 2001. Dietary and genetic effects on low-density lipoprotein heterogeneity. Ann. Rev. Nutr. 21, 283-295.
51. Krinsky, N.I. 1993. Actions of carotenoids in biological systems, Ann. Rev. Nutr. 13, 561-587.
52. Kris-Etherton, P.M., Binkoski, A.E., Zhao, G., Coval, S.M., Clemmer, K.F., Hecker, K.D., Jacques, H., Etherton, T.D. 2002. Dietary fat: assessing the evidence in support of a moderate-fat diet; the benchmark based on lipoprotein metabolism. Proc. Nutr. Soc. 61, 287-298.
53. Kritchevsky, D. 1999. Conjugated linoleic acid and experimental atherosclerosis in rabbits. In: Advances in Conjugated Linoleic Acid Research, Vol. 1 (M.P. Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza, G.J. Nelson, eds.), pp. 397-403, American Oil Chemists' Society Press, Champaign, IL.
54. Kritchevsky, D. 2003. Conjugated linoleic acid in experimental atherosclerosis. In: Advances in Conjugated Linoleic Acid Research, Vol. 2 (J-L. Sebedio, W.W. Christie, R.O. Adlof, eds.), pp. 292-301, American Oil Chemists' Society Press, Champaign, IL.
55. Kritchevsky, S.B., Kritchevsky, D. 2000. Egg consumption and coronary heart disease: an epidemiologic overview. J. Am. Coll. Nutr. 19, 549S-555S.
56. Kushi, L., Giovannucci, E. 2002. Dietary fat and cancer. Am. J. Med. 113, 63S-70S.
57. Kuulasmaa, K., Tynstall-Pedoe, H., Dobson, A., Fortmann, S., Sans, S., Tolonen, H., Evans, A., Ferrario, M., Tuomilehto, J. 2000. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA project populations. Lancet. 355, 675-687.
58. Lafontan, M., Berlan, M. 2003. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol. Sci. 24, 276-283.
59. Lemonnier, L.A., Dillehay, D.L., Vespremi, M.J., Abrams, J., Brody, E., Schmelz, E.M. 2003. Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch. Biochem. Biophys. 419, 129-138.
60. Maron, D.J., Fazio, S., Linton, M.F. 2000. Current perspectives on statins. Circulation. 101, 207-213.
61. Masso-Welch, P.A., Zangani, D., Ip, C., Vaughan, M.M., Shoemaker, S.F., McGee, S.O., Ip, M.M. 2004. Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature. J. Nutr. 134, 299-307.
62. Mauger, J-F., Lichtenstein, A.H., Ausman, L.M., Jalbert, S.M., Jauhiainen, M., Ehnholm, C., Lamarche, B. 2003. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am. J. Clin. Nutr. 78, 370-375.
63. McCann, S.E., Ip, C., Ip, M.M., McGuire, M.K., Muti, P., Edge, S.B., Trevisan, M., Freudenheim, J.L. 2004. Dietary intake of conjugated linoleic acid and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol. Biomark. Prev. 13, 1480-1484.
64. McDevitt, R.M., Poppitt, S.D., Murgatroyd, P.R., Prentice, A.M. 2000. Macronutrient disposal during controlled overfeeding with glucose, fructose, sucrose, or fat in lean and obese women. Am. J. Clin. Nutr. 72, 369-377.
65. McNamara, D.J. 2000. Dietary cholesterol and atherosclerosis. Biochim. Biophys. Acta. 1529, 310-320.
66. Mensink, R.P., Zock, P.L., Katan, M.P., Hornstra, G. 1992. Effect of dietary cis and trans fatty acids on serum lipoprotein[a] levels in humans. J. Lipid Res. 33, 1493-1501.
67. Mensink, R.P., Zock, P.L., Kester, A.D.M., Katan, M.B. 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77, 1146-1155.
68. Missmer, S.A., Smith-Warner, S.A., Spiegelman, D., Yuan, S-S., Adami, H-O., Beeson, W.L., van den Brandt, P.A., Fraser, G.E., Freudenheim, J.L., Goldbohm, R.A., Graham, S., Kushi, L.H., Miller, A.B., Potter, J.D., Rohan, T.E., Speizer, F.E., Toniolo, P., Willett, W.C., Wolk, A., Zeleniuch-Jacquotte, A., Hunter, D.J. 2002. Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int. J. Epidemiol. 31, 78-85.
69. Moschetta, A., van Berge-Henegouwen, G.P., Portincasa, P., Palasciano, G., Groen, A.K., van Erpecum, K.J. 2000. Sphingomyelin exhibits greatly enhanced protection compared with egg yolk phosphatidylcholine against detergent bile salts. J. Lipid Res. 41, 916-924.
70. Muldoon, M.F., Manuck, S.B., Matthews, K.A. 1990. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. Brit. Med. J. 301, 309-314.
71. Niles, R.M. 2000. Vitamin A and cancer. Nutrition. 16, 573-576.
72. Nyberg, L., Nilsson, A., Lundgren, P., Duan, R-D. 1997. Localization and capacity of sphingomyelin digestion in the rat intestinal tract. J. Nutr. Biochem. 8, 112-118.
73. Oomen, C.M., Ocke, M.C., Feskens, E.J.M., van Erp-Baart, M-A.J., Kok, F.J., Kromhout, D. 2001. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet. 357, 746-751.
74. Parodi, P.W. 2001a. An assessment of the evidence linking calcium and vitamin D to colon cancer prevention. Aust. J. Dairy Technol. 56, 38-58.
75. Parodi, P.W. 2001b. Cow's milk components with anti-cancer potential. Aust. J. Dairy Technol. 56, 65-73.
76. Parodi, P.W. 2004. Milk fat in human nutrition. Aust. J. Dairy Technol. 59, 3-58.
77. Pekkanen, J., Linn, S., Heiss, G., Suchindran, C.M., Leon, A., Rifkind B.M., Tyroler, H.A. 1990. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N. Engl. J. Med. 322, 1700-1707.
78. Pietinen, P., Ascherio, A., Korhonen, P., Hartman A.M., Willett, W.C., Albanes, D., Virtamo, J. 1997. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Epidemiol. 145, 876-887.
79. Pirozzo, S., Summerbell, C., Cameron, C., Glasziou, P. 2003. Should we recommend low-fat diets for obesity? Obesity Rev. 4, 83-90.
80. Pouillart, P.R. 1998. Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies. Life Sci. 63, 1739-1760.
81. Ravnskov, U. 1992. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. Br. Med. J. 305, 15-19.
82. Ravnskov, U. 1995. Quotation bias in reviews of the diet-heart idea. J. Clin. Epidemiol. 48, 713-719.
83. Ravnskov, U. 1998. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J. Clin. Epidemiol. 51, 443-460.
84. Russell, R.M. 2004. The enigma of β-carotene in carcinogenesis: what can be learned from animal studies. J. Nutr. 134, 262S-268S.
85. Sacks, F.M., Moye, L.A., Davis, B.R., Cole, T.G., Rouleau, J.L., Nash, D.T., Pfeffer, M.A., Braunwald, E. 1998. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial. Circulation. 97, 1446-1452.
86. Sacks, F.M., Tonkin, A.M., Shepherd, J., Braunwald, E., Cobbe, S., Hawkins, C.M., Keech, A., Packard, C., Sims, J., Byington, R., Furberg, C.D. 2000. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors. Circulation. 102, 1893-1900.
87. Sanders, T.A.B. 2003. High-versus low-fat diets in human diseases. Curr. Opin. Clin. Nutr. Metab. Care. 6, 151-155.
88. Santora, J.E., Palmquist, D.L., Roehrig, K.L. 2000. Trans-vaccenic acid is desaturated to conjugated linoleic acid in mice. J. Nutr. 130, 208-215.
89. Schaefer, E.J. 2002. Lipoproteins, nutrition, and heart disease. Am. J. Clin. Nutr. 75, 191-212.
90. Schmelz, E.M., Dillehay, D.L., Webb, S.K., Reiter, A., Adams, J., Merrill, A.H. 1996. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res. 56, 4936-4941.
91. Schmelz, E.M., Bushnev, A.S., Dillehay, D.L., Liotta, D.C., Merrill, A.H. 1997. Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones. Nutr. Cancer. 28, 81-85.
92. Schmelz, E.M., Sullards, M.C., Dillehay, D.L., Merrill, A.H. 2000. Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. J. Nutr. 130, 522-527.
93. Schmelz, E.M., Roberts, P.C., Kustin, E.M., Lemonnier, L.A., Sullards, M.C., Dillehay, D.L., Merrill, A.H. 2001. Modulation of intracellular β-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res. 61, 6723-6729.
94. Schneeman, B.O., Burton-Freeman, B., Davis, P. 2003. Incorporating dairy foods into low and high fat diets increases the postprandial cholecystokinin response in men and women, J. Nutr. 133, 4124-4128.
95. Seidell, J.C. 1998. Dietary fat and obesity: an epidemiologic perspective. Am. J. Clin. Nutr. 67, 546S-550S.
96. Selzner, M., Bielawska, A., Morse, M.A., Rudiger, H.A., Sindram, D., Hannun, Y.A., Clavien, P-A. 2001. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 61, 1233-1240.
97. Smith-Warner, S.A., Spiegelman, D., Adami, H-O., Beeson, W.L., van den Brandt, P.A., Folsom, A.R., Fraser, G.E., Freudenheim, J.L., Goldbohm, R.A., Graham, S., Kushi, L.H., Miller, A.B., Rohan, T.E., Speizer, F.E., Toniolo, P., Willett, W.C., Wolk, A., Zeleniuch-Jacquotte, A., Hunter, D.J. 2001. Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int. J. Cancer. 92, 767-774.
98. Stamler, J., Wentworth, D., Neaton, J.D. 1986. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? J. Am. Med. Assoc. 256, 2823-2828.
99. Studzinski, G.P., Moore, D.C. 1995. Sunlight-can it prevent as well as cause cancer? Cancer Res. 55, 4014-4022.
100. Takemoto, M., Liao, J.K. 2001. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21, 1721-1719.
101. -/- mouse by conjugated linoleic acid. Biochem. Soc. Trans. 31, 1075-1079.
102. Turpeinen, A.M., Mutanen, M., Aro, A., Salminen, I., Basu, S., Palmquist, D.L., Grinnari, J.M. 2002. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am. J. Clin. Nutr. 76, 504-510.
103. Urquhart, P., Parkin, S.M., Rogers. J.S., Bosley, J.A., Nicolaou, A. 2002. The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoids production in human saphenous vein endothelial cells. Biochim. Biophys. Acta. 1580, 150-160.
104. van den Bemd, G-J.C.M., Pols, H.A.P. and van Leeuwen, P.T.M. 2000. Anti-tumor effects of 1, 25-dihydroxyvitamin D3 and vitamin D analogs. Curr. Pharm. Des. 6, 717-732.
105. van Leeuwen, J.P.T.M., Pols, H.A.P. 1997. Vitamin D: anticancer and differentiation. In: Vitamin D (D. Feldman, F.H. Glorieux, J.W. Pike, eds.), pp. 1089-1105, Academic Press, San Diego.
106. Verschuren, W.M.M., Jacobs, D.R., Bloemberg, B.P.M., Kromhout, D., Menotti, A., Aravanis, C., Blackburn, H., Buzina, R., Dontas, A.S., Fidanza, F., Karvonen, M.J., Nedeljkovic, S., Nissinen, A., Toshima, H. 1995. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries Study. J. Am. Med. Assoc. 274, 131-136.
107. Vesper, H., Schmelz, E-M., Nikolova-Karakashian, M.N., Dillehay, D L., Lynch, D.V., Merrill, A.H. 1999. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J. Nutr. 129, 1239-1250.
108. Warensjo, E., Jansson, J-H., Berglund, L., Boman, K., Ahren, B., Weinehall, L., Lindahl, B., Hallmans, G., Vessby, B. 2004. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a Wrst acute myocardial infarction. A prospective case-control study. Br. J. Nutr. 91, 635-642.
109. Williams, E.A., Coxhead, J.M., Mathers, J.C. 2003. Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms. Proc. Nutr. Soc. 62, 107-115.
110. Willett, W.C. 1997. Specific fatty acids and risks of breast and prostate cancer: dietary intake. Am. J. Clin. Nutr. 66, 1557S-1563S.
111. Willett, W.C. 2001a. Diet and cancer: one view at the start of the millennium. Cancer Epidemiol. Biomark. Prev. 10, 3-8.
112. Willett, W.C. 2001b. Diet and breast cancer. J. Intern. Med. 249, 395-411.
113. Willett, W.C. 2002. Dietary fat plays a major role in obesity: no. Obesity Rev. 3, 59-68.
114. Willett, W.C., Stampfer, M.J., Manson, J.E., Colditz, G.A., Speizer, F.E., Rosner, B.A., Sampson, L.A., Hennekens, C.H. 1993. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 341, 581-585.
115. Wongtangtintharn, S.,Oku,H., Iwasaki, H., Toda, T. 2004.Effect of branched-chain fatty acidson fatty acid biosynthesis of human breast cancer cells. J. Nutr. Sci. Vitaminol. 50, 137-143.
116. Yanagi, S., Yamashita, M., Imai, S. 1993. Sodium butyrate inhibits the enhancing effect of high fat diet on mammary tumorigenesis. Oncology. 50, 201-204.
117. Yang, Z., Liu, S., Chen, X., Chen, H., Huang, M., Zheng, J. 2000. Induction of apoptotic cell death and in vivo growth inhibition of human cancer cells by a saturated branched-chain fatty, 13-methyltetradecanoic acid. Cancer Res. 60, 505-509.
118. Yin, L., Laevsky, G., Giardina, C. 2001. Butyrate suppression of colonocyte NF-κB activation and cellular proteasome activity. J. Biol. Chem. 276, 44641-44646.
119. Yu, Y., Correll, P.H., Vanden Heuvel, J.P. 2002. Conjugated linoleic acid decreases the production of pro-inflammatory products in macrophages: evidence for a PPARg-dependent mechanism. Biochim. Biophys. Acta. 1581, 89-99.
120. Zittermann, A. 2003. Vitamin D in preventive medicine: are we ignoring the evidence? Br. J. Nutr. 89, 552-572.